Learn more at LeadIQ.com

Insights

Strategic Partnerships Ablynx N.V has established strategic partnerships with companies like Taisho Pharmaceutical Co., LabGenius, and Translate Bio, indicating potential collaboration opportunities for sales expansion by leveraging these existing relationships.

Market Expansion The acquisition of Corvidia and the ongoing development of an mRNA vaccine for Covid-19 demonstrate Ablynx's focus on expanding into new therapeutic areas, presenting sales opportunities in emerging markets and diversified product portfolios.

Innovative Technology Ablynx's use of innovative technologies like Nanobodies® positions the company as a pioneer in the biotechnology research industry, offering sales professionals the chance to showcase cutting-edge solutions to potential clients.

Financial Strength With reported revenue between $50M - $100M and funding of $230M, Ablynx N.V exhibits financial stability and growth potential, providing a strong foundation for sales negotiations and long-term partnerships.

Competitive Positioning Ablynx N.V's competitive landscape includes key players like Gilead Sciences, Novartis, and Biogen, offering insights for sales teams to differentiate and position Ablynx's offerings as unique solutions in a crowded market.

Similar companies to Ablynx

Ablynx Tech Stack

Ablynx uses 8 technology products and services including SAS, Docker, SAP, and more. Explore Ablynx's tech stack below.

SAS
Business Intelligence
Docker
Containerization
SAP
Customer Relationship Management
Eblox
E-commerce Platforms
CTT
Logistics
Linux
Programming Languages
IIS
Web Servers
Twitter
Widgets

Media & News

Ablynx's Email Address Formats

Ablynx uses at least 1 format(s):

Ablynx Email Formats	Example	Percentage
First.Last@ablynx.com	John.Doe@ablynx.com	80%
FLast@ablynx.com	JDoe@ablynx.com	13%
FMiddleLast@ablynx.com	JMichaelDoe@ablynx.com	5%
First.Middle.Last@ablynx.com	John.Michael.Doe@ablynx.com	2%

Frequently Asked Questions

Where is Ablynx's headquarters located?

Ablynx's main headquarters is located at Technologiepark 21 Zwijnaarde (Ghent), 9052 BE. The company has employees across 5 continents, including EuropeNorth AmericaSouth America.

What is Ablynx's phone number?

You can contact Ablynx's main corporate office by phone at

+1-329-262-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ablynx's stock symbol?

Ablynx is a publicly traded company; the company's stock symbol is ABLX.

What is Ablynx's official website and social media links?

Ablynx's official website is ablynx.com and has social profiles on LinkedIn.

How much revenue does Ablynx generate?

As of September 2024, Ablynx's annual revenue reached $75M.

What is Ablynx's SIC code NAICS code?

Ablynx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ablynx have currently?

As of September 2024, Ablynx has approximately 201 employees across 5 continents, including EuropeNorth AmericaSouth America. Key team members include Head Glp Qa: C. D.Head Of Bioanalysis And Immunogenicity: S. P.Executive Assistant To Chief Medical Officer: R. V. R.. Explore Ablynx's employee directory with LeadIQ.

What industry does Ablynx belong to?

Ablynx operates in the Biotechnology Research industry.

What technology does Ablynx use?

Ablynx's tech stack includes SASDockerSAPEbloxCTTLinuxIISTwitter.

What is Ablynx's email format?

Ablynx's email format typically follows the pattern of . Find more Ablynx email formats with LeadIQ.

How much funding has Ablynx raised to date?

As of September 2024, Ablynx has raised $230M in funding. The last funding round occurred on Oct 30, 2017 for $230M.

Ablynx

Ablynx

Biotechnology ResearchZwijnaarde (Ghent), Belgium201-500 Employees

Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Nanobodies have potential uses in the treatment of a range of serious and life-threatening human diseases. Ablynx advances a portfolio of Nanobody-based therapeutic programs in several major disease areas, including inflammation, haematology, immuno-oncology and oncology.

The acquisition of Ablynx (June 2018) continues Sanofi’s commitment to breakthrough innovation, focused on technologies addressing multiple disease targets with single multi-specific molecules. Sanofi is committed to accelerating Ablynx’s Nanobody development programmes.

Company Overview

Headquarters: Technologiepark 21 Zwijnaarde (Ghent), 9052 BE
Phone number: ✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-329-262-****
Website: ablynx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ABLX
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 201-500

Media & News

Funding & Financials

$230M
Ablynx has raised a total of $230M of funding over 8 rounds. Their latest funding round was raised on Oct 30, 2017 in the amount of $230M.
$50M$100M
Ablynx's revenue is in the range of $50M$100M

Funding & Financials

$230M
Ablynx has raised a total of $230M of funding over 8 rounds. Their latest funding round was raised on Oct 30, 2017 in the amount of $230M.
$50M$100M
Ablynx's revenue is in the range of $50M$100M

Company Leadership

C. D.
Head Glp Qa
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. P.
Head Of Bioanalysis And Immunogenicity
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. V. R.
Executive Assistant To Chief Medical Officer
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
O. N.
Sr. Principal Scientist, Group Head Validation
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. D.
Group Head Of Cmc Analytics
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. D.
Head Glp Qa
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. S.
Principal Scientist - Lab Head
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. V.
Section Head - Discovery Functional Profiling Unit
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. D.
Regional Head Sces Qa Operations Eu And International
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. W.
Section Head Biostatistics
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ablynx and Millions of Other Companies
Sign up for full access to Ablynx information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.